首页 | 本学科首页   官方微博 | 高级检索  
     

长链非编码RNA MEG3靶向Rac1抑制宫颈癌细胞增殖、迁移的实验研究
引用本文:王冰,徐臻,赵虎,张海玲,王武亮,周晓水. 长链非编码RNA MEG3靶向Rac1抑制宫颈癌细胞增殖、迁移的实验研究[J]. 临床肿瘤学杂志, 2019, 24(2): 119-123
作者姓名:王冰  徐臻  赵虎  张海玲  王武亮  周晓水
作者单位:郑州大学第二附属医院妇产科, 450000 郑州;郑州大学第二附属医院肿瘤科, 450000
摘    要:目的检测长链非编码RNA MEG3在宫颈癌细胞中的表达,检测MEG3表达对He La细胞增殖、迁移的影响及可能分子机制。方法采用荧光定量PCR(QPCR)检测正常宫颈上皮细胞Hcer Epic和宫颈癌细胞系C-33A、C4-1、Caski、Si Ha和He La中MEG3的表达; MEG3过表达质粒(MEG3)、阴性对照质粒(NC组)、MEG3+Rac1过表达质粒(MEG3+Rac1组)分别转染He La细胞,MTT法检测细胞增殖情况,Transwell实验检测细胞迁移能力,Western blotting检测PCNA、E-cadenin、N-cadenin、Vimentin、Rac1蛋白表达。结果 QPCR结果显示,C-33A、C4-1、Caski、Si Ha和He La细胞中MEG3表达水平分别为0. 37±0. 044、0. 65±0. 075、0. 41±0. 071、0. 71±0. 053和0. 42±0. 081,均低于Hcer Epic细胞的1. 02±0. 064,差异具有统计学意义(P<0. 05)。MTT法结果显示MEG3组He La细胞增殖活力显著低于NC组; MEG3组的迁移细胞数为385±14,显著低于NC组的594±16(P<0. 05);与NC组比较,MEG3组PCNA、N-cadenin和Vimentin表达下调,E-cadenin表达上调。与MEG3组比较,MEG3+Rac1组显著上调Rac1蛋白表达,上调He La细胞增殖活力,增加迁移细胞数。结论 LncRNA MEG3可能通过靶向Rac1信号通路抑制宫颈癌细胞增殖、迁移。

关 键 词:宫颈癌  MEG3  RAC1  增殖  迁移
收稿时间:2018-09-13
修稿时间:2018-11-22

Long chain non-coding RNA MEG3 targeting Rac1 inhibitsproliferation and migration of cervical cancer cells
WANG Bing,XU Zhen,ZHAO Hu,ZHANG Hailing,WANG Wuliang,ZHOU Xiaoshui.. Long chain non-coding RNA MEG3 targeting Rac1 inhibitsproliferation and migration of cervical cancer cells[J]. Chinese Clinical Oncology, 2019, 24(2): 119-123
Authors:WANG Bing  XU Zhen  ZHAO Hu  ZHANG Hailing  WANG Wuliang  ZHOU Xiaoshui.
Affiliation:(Department of Obstetrics and Gynecology,the Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)
Abstract:Objective To detect theexpression of long chain non-coding RNA MEG3 in cervical cancer cells, and to detect the effect of MEG3 on the proliferation andmigration of HeLa cells and its possible molecular mechanism. Methods Theexpression of MEG3 in normal cervical epithelial cells HcerEpic and cervicalcancer cell lines C-33A, C4-1, Caski, SiHaand HeLa was detected by fluorescence quantitative PCR (QPCR). MEG3overexpression plasmid (MEG3group), negative control plasmid (NC group) andMEG3+Rac1 overexpression plasmid (MEG3+Rac1 group) weretransfected into HeLa cells respectively. MTT assay was used to detect cellproliferation and Transwell assay was used to detect cell migration. Theexpression of PCNA, E-cadenin, N-cadenin,Vimentin and Rac1 was detected by Western blotting assay. Results Theexpression levels of MEG3 in C-33A, C4-1, Caski, SiHa and HeLa cells were 0.37±0.044, 0.65±0.075, 0.41±0.071, 0.71±0.053 and 0.42±0.081, which were lower than those in HcerEpic cells (P<0.05). MTT assay showed that the proliferation activity of HeLa cells inMEG3 group was significantly lower than that in NC group. The number ofmigrating cells in MEG3 group was 385±14, whichwas significantly lower than that in NC group (594±16),and the difference was statistically significant (P<0.05). Compared with NC group, the expressions of PCNA, N-cadenin and Vimentin were down-regulated and E-cadenin was up-regulatedin MEG3 group. Compared with MEG3 group, MEG3+Rac1 group significantly increased the expression of Rac1protein, theproliferation activity and the number of migrating cells. Conclusion LncRNAMEG3 inhibits the proliferation and migration of cervical cancer cells bytargeting Rac1 signaling pathway.
Keywords:"  >Cervical cancer, Maternallyexpressed gene 3(MEG3), Rac1, Proliferation, Migration
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号